Fascin Presents Novel Therapeutic Target for Chemoresistant/Metastatic Breast Cancer

@inproceedings{AlAlwan2016FascinPN,
  title={Fascin Presents Novel Therapeutic Target for Chemoresistant/Metastatic Breast Cancer},
  author={Monther Al-Alwan and Rayanah Barnawi and Samiyah Al‐Khaldi and Hazem Ghebeh},
  year={2016}
}
Monther Al-Alwan1*, Rayanah Barnawi1, Samiyah Alkhaldi2 and Hazem Ghebeh1 1Stem Cell and Tissue Re-engineering Program, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia 2National Genome Center, King Abdulaziz City for Sciences and Technology, Riyadh, Saudi Arabia *Corresponding author: Monther Al-Alwan, Stem Cell and Tissue Re-engineering Program, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia, Tel: 00966114647272; E-mail: MAlwan@kfshrc.edu.sa 

Topics from this paper.

Citations

Publications citing this paper.

Review on Cancer

VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 11 REFERENCES

3983-3988

M Al-Hajj, MS Wicha, A Benito-Hernandez, SJ Morrison, A 100ClarkeMFProspectiveidentificationoftumorigenicb
  • Citation: Al-Alwan M, Barnawi R, Alkhaldi S, Ghebeh H
  • 2016
VIEW 1 EXCERPT

NF-kappaB in cancer: a marked target.

  • Seminars in cancer biology
  • 2003
VIEW 1 EXCERPT

Activation of the PI3K/Akt pathway and chemotherapeutic resistance.

  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
  • 2002
VIEW 1 EXCERPT

Similar Papers

Loading similar papers…